|
US20090297602A1
(en)
*
|
1998-11-02 |
2009-12-03 |
Devane John G |
Modified Release Loxoprofen Compositions
|
|
PL205109B1
(pl)
|
1998-11-02 |
2010-03-31 |
Elan Pharma Int Ltd |
Wielocząstkowa kompozycja metylofenidatu o modyfikowanym uwalnianiu i jej zastosowanie
|
|
CA2354472C
(en)
*
|
1998-12-17 |
2009-02-24 |
Alza Corporation |
Conversion of liquid filled gelatin capsules into controlled release systems by multiple coatings
|
|
WO2001041742A2
(en)
*
|
1999-12-09 |
2001-06-14 |
Alza Corporation |
Antiviral medication
|
|
AR026148A1
(es)
*
|
2000-01-21 |
2003-01-29 |
Osmotica Argentina S A |
Dispositivo osmotico con pasaje preformado que aumenta de tamano
|
|
EP1411901B1
(en)
*
|
2001-07-04 |
2010-08-18 |
Sun Pharma Advanced Research Company Ltd |
Gastric retention controlled drug delivery system
|
|
US6720002B2
(en)
*
|
2001-07-20 |
2004-04-13 |
R.P. Scherer Technologies, Inc. |
Antihistamine formulations for soft capsule dosage forms
|
|
MXPA04006026A
(es)
*
|
2001-12-19 |
2005-03-31 |
Alza Corp |
Formulacion y forma de dosificacion para aumentar la biodisponibilidad oral de macromoleculas hidrofilitas.
|
|
US20030232078A1
(en)
*
|
2001-12-19 |
2003-12-18 |
Dong Liang C. |
Formulation & dosage form for the controlled delivery of therapeutic agents
|
|
KR101046903B1
(ko)
*
|
2002-06-26 |
2011-07-06 |
인타르시아 세라퓨틱스 인코포레이티드 |
삼투성 약물 전달 시스템을 위한, 최소로 튀는 용적효율성 피스톤
|
|
MXPA05000206A
(es)
*
|
2002-06-28 |
2005-12-05 |
Johnson & Johnson |
Forma de dosificiacion oral que comprende una formulacion liquida de agente activo y liberacion controlada de la misma mediante una composicion osmotica expansible.
|
|
TW200414900A
(es)
*
|
2002-06-28 |
2004-08-16 |
|
|
|
US20050232995A1
(en)
|
2002-07-29 |
2005-10-20 |
Yam Nyomi V |
Methods and dosage forms for controlled delivery of paliperidone and risperidone
|
|
KR100699516B1
(ko)
*
|
2002-07-29 |
2007-03-26 |
알자 코포레이션 |
팔리페리돈의 조절 전달을 위한 방법 및 복용 형태
|
|
MXPA05004251A
(es)
*
|
2002-10-21 |
2005-07-05 |
Givaudan Sa |
Composiciones pesticidas.
|
|
US20040142040A1
(en)
*
|
2002-10-31 |
2004-07-22 |
Dong Liang C. |
Formulation and dosage form providing increased bioavailability of hydrophobic drugs
|
|
EP1556017A1
(en)
*
|
2002-10-31 |
2005-07-27 |
ALZA Corporation |
Dosage form providing ascending release of liquid formulation
|
|
US7988993B2
(en)
*
|
2002-12-09 |
2011-08-02 |
Andrx Pharmaceuticals, Inc. |
Oral controlled release dosage form
|
|
US7731947B2
(en)
|
2003-11-17 |
2010-06-08 |
Intarcia Therapeutics, Inc. |
Composition and dosage form comprising an interferon particle formulation and suspending vehicle
|
|
US20040131672A1
(en)
*
|
2003-01-07 |
2004-07-08 |
Nilobon Podhipleux |
Direct compression pharmaceutical composition containing a pharmaceutically active ingredient with poor flowing properties
|
|
US7037521B2
(en)
*
|
2003-03-28 |
2006-05-02 |
Bausch & Lomb Incorporated |
Using a laser for cutting a hole in a capsule for controlled drug delivery
|
|
DE602004016995D1
(de)
|
2003-06-26 |
2008-11-20 |
Control Delivery Sys Inc |
In-situ gelierendes arzneimittelabgabesystem
|
|
TWI367103B
(en)
|
2003-06-26 |
2012-07-01 |
Psivida Inc |
Bioerodible sustained release drug delivery systems
|
|
CN1842321B
(zh)
*
|
2003-06-26 |
2012-07-04 |
控制递送系统有限公司 |
生物蚀解性缓释递药系统
|
|
US20050003070A1
(en)
*
|
2003-07-03 |
2005-01-06 |
Foster David V. |
Shelf stable vitamin C in oatmeal products
|
|
BRPI0412523A
(pt)
*
|
2003-07-11 |
2006-09-19 |
Hoffmann La Roche |
forma de dosagem oral de mesilato de saquinavir
|
|
PT2279729T
(pt)
*
|
2003-07-17 |
2016-09-22 |
Banner Life Sciences Llc |
Preparações de libertação controlada
|
|
NZ527142A
(en)
*
|
2003-07-23 |
2006-03-31 |
Douglas Pharmaceuticals Ltd |
A stable suspension formulation
|
|
EP1648409A2
(en)
*
|
2003-07-31 |
2006-04-26 |
Alza Corporation |
Permeation-resistant osmotic engine and dosage form for controlled release of a liquid active agent formulation
|
|
ES2336913T3
(es)
*
|
2003-08-08 |
2010-04-19 |
Biovail Laboratories International Srl |
Comprimido de liberacion modificada de hidrocloruro de bupropion.
|
|
MXPA06003451A
(es)
*
|
2003-09-26 |
2006-08-31 |
Johnson & Johnson |
Formas de dosificacion osmotica para suministro controlado de alprazolam.
|
|
EP1689367A1
(en)
*
|
2003-10-21 |
2006-08-16 |
Actavis Group HF |
Pharmaceutical formulations containing quetiapine
|
|
EP1684713A1
(en)
*
|
2003-11-14 |
2006-08-02 |
ALZA Corporation |
Controlled release of topirimate in liquid dosage forms
|
|
US20050181049A1
(en)
*
|
2003-11-19 |
2005-08-18 |
Dong Liang C. |
Composition and method for enhancing bioavailability
|
|
US20050181050A1
(en)
*
|
2004-01-28 |
2005-08-18 |
Collegium Pharmaceutical, Inc. |
Dosage forms using drug-loaded ion exchange resins
|
|
EP1593376A1
(en)
*
|
2004-05-04 |
2005-11-09 |
Warner-Lambert Company LLC |
Improved pullulan capsules
|
|
WO2006058059A2
(en)
|
2004-11-23 |
2006-06-01 |
Neuromolecular Pharmaceuticals, Inc. |
Composition comprising a sustained release coating or matrix and an nmda receptor antagonist, method for administration such nmda antagonist to a subject
|
|
US7619007B2
(en)
|
2004-11-23 |
2009-11-17 |
Adamas Pharmaceuticals, Inc. |
Method and composition for administering an NMDA receptor antagonist to a subject
|
|
EP1845968A2
(en)
|
2004-11-24 |
2007-10-24 |
Neuromolecular Pharmaceuticals, Inc |
Composition comprising an nmda receptor antagonist and levodopa and use thereof for treating neurological disease
|
|
WO2006063078A2
(en)
*
|
2004-12-08 |
2006-06-15 |
Elan Corporation, Plc |
Topiramate pharmaceuticals composition
|
|
EP1827377B1
(en)
*
|
2004-12-14 |
2008-03-19 |
Novartis AG |
In-situ forming implant for animals
|
|
CA2596029A1
(en)
*
|
2005-01-27 |
2006-08-03 |
David E. Edgren |
Oral osmotic dosage form having a high flux membrane
|
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
|
WO2006083761A2
(en)
|
2005-02-03 |
2006-08-10 |
Alza Corporation |
Solvent/polymer solutions as suspension vehicles
|
|
MX2007012374A
(es)
|
2005-04-06 |
2008-02-22 |
Adamas Pharmaceuticals Inc |
Metodos y composiciones para el tratamiento de condiciones relacionadas con cns.
|
|
CN101232868A
(zh)
*
|
2005-04-19 |
2008-07-30 |
阿尔扎公司 |
曲马多和加巴喷丁的控释递药剂型
|
|
WO2007037790A2
(en)
*
|
2005-06-08 |
2007-04-05 |
Elan Corporation, Plc |
Modified release famciclovir compositions
|
|
AR055099A1
(es)
*
|
2005-07-28 |
2007-08-08 |
Alza Corp |
Formulaciones liquidas para la administracion controlada de derivados de bencisoxazol
|
|
US20070082046A1
(en)
*
|
2005-10-11 |
2007-04-12 |
Banner Pharmacaps, Inc. |
Enteric valproic acid
|
|
JP5303276B2
(ja)
*
|
2005-10-12 |
2013-10-02 |
プロヴェンティヴ セラピュティックス リミテッド ライアビリティ カンパニー |
２５−ヒドロキシビタミンｄ不足および欠乏を治療するための方法および製品
|
|
WO2007044910A1
(en)
*
|
2005-10-13 |
2007-04-19 |
Duke University |
Compositions for the treatment and prevention of heart disease and methods of using same
|
|
US20070087055A1
(en)
*
|
2005-10-14 |
2007-04-19 |
David Jan |
Directly compressible extended release alprazolam formulation
|
|
US20070092559A1
(en)
*
|
2005-10-24 |
2007-04-26 |
Jinghua Yuan |
Liquid dosage forms having enteric properties of delayed and then sustained release
|
|
PL116330U1
(en)
*
|
2005-10-31 |
2007-04-02 |
Alza Corp |
Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation
|
|
CA2882048C
(en)
*
|
2006-02-03 |
2020-03-24 |
Proventiv Therapeutics, Llc |
Treating vitamin d insufficiency and deficiency with 25-hydroxyvitamin d2 and 25-hydroxyvitamin d3
|
|
US20070196487A1
(en)
*
|
2006-02-16 |
2007-08-23 |
Geerke Johan H |
Method and apparatus for drilling orifices in osmotic tablets incorporating near-infrared spectroscopy
|
|
KR101106510B1
(ko)
|
2006-05-30 |
2012-01-20 |
인타르시아 세라퓨틱스 인코포레이티드 |
투피스, 내부채널 삼투압 전달 시스템 유동 조절기
|
|
US20070281008A1
(en)
*
|
2006-06-05 |
2007-12-06 |
Lin Shun Y |
Personal lubricant compositions and kits for providing personal lubrication
|
|
DK3357496T3
(da)
|
2006-06-21 |
2020-05-11 |
Opko Ireland Global Holdings Ltd |
Terapi ved brug af vitamin d-repletteringsmiddel og vitamin d-hormonsubstitutionsmiddel
|
|
DE102006032426A1
(de)
*
|
2006-07-13 |
2008-01-17 |
Neuraxpharm Arzneimittel Gmbh U. Co. Kg |
Verwendung von Zusammensetzungen von Clozapin, Quetiapin, schwer oder sehr schwer löslichen Säureadditionssalzen von Quetiapin und/oder Olanzapin zur Herstellung von Lösungen zur oralen Verabreichung
|
|
DE102006032427A1
(de)
*
|
2006-07-13 |
2008-01-17 |
Neuraxpharm Arzneimittel Gmbh U. Co. Kg |
Verwendung von Zusammensetzungen von Clozapin, Quetiapin, schwer oder sehr schwer löslichen Säureadditionssalzen von Quetiapin und/oder Olanzapin zur Herstellung von Lösungen zur oralen Verabreichung
|
|
US20080038334A1
(en)
*
|
2006-08-08 |
2008-02-14 |
John Zazula |
Method for producing and a system for cooling a hot-filled softgel capsule
|
|
AU2007284759B2
(en)
|
2006-08-09 |
2010-10-28 |
Intarcia Therapeutics, Inc. |
Osmotic delivery systems and piston assemblies
|
|
EP2106732B1
(en)
*
|
2007-01-30 |
2016-03-16 |
Olympus Corporation |
Device for checking for lumen passage and method of producing device for checking for lumen passage
|
|
US8524749B2
(en)
*
|
2007-02-09 |
2013-09-03 |
Alza Corporation |
Controlled release compositions of tizanidine
|
|
RU2440097C2
(ru)
|
2007-04-23 |
2012-01-20 |
Интарсия Терапьютикс, Инк. |
Способ лечения диабета ii типа и ожирения, осмотическое устройство для доставки и способ его изготовления
|
|
ES2956794T3
(es)
|
2007-04-25 |
2023-12-28 |
Eirgen Pharma Ltd |
Liberación controlada de 25-hidroxivitamina D
|
|
US8592401B2
(en)
|
2007-04-25 |
2013-11-26 |
Proventiv Therapeutics, Llc |
Methods and compounds for vitamin D therapy
|
|
EP2148683A4
(en)
|
2007-04-25 |
2012-09-12 |
Proventiv Therapeutics Llc |
METHOD FOR THE SAFE AND EFFECTIVE TREATMENT AND PREVENTION OF SECONDARY HYPERPARATHYREOSIS IN CHRONIC KIDNEY DISEASE
|
|
KR101495578B1
(ko)
|
2007-04-25 |
2015-02-25 |
사이토크로마 인코포레이티드 |
비타민 ｄ 부족 및 결핍의 치료 방법
|
|
MX2009007764A
(es)
*
|
2007-06-08 |
2009-09-10 |
Boehringer Ingelheim Pharma |
Formulacion de nevirapina de liberacion prolongada.
|
|
BRPI0815387B8
(pt)
*
|
2007-08-13 |
2021-05-25 |
Abuse Deterrent Pharmaceutical Llc |
composição farmacêutica, método para fazer uma composição farmacêutica e uso da composição farmacêutica
|
|
CN101827572A
(zh)
*
|
2007-10-15 |
2010-09-08 |
葛兰素集团有限公司 |
用于释放药物组合物的有板条的胶囊壳
|
|
EP2219583B1
(en)
*
|
2007-10-15 |
2012-11-21 |
Capsugel Belgium NV |
Method and apparatus for manufacturing filled linkers
|
|
EP2537506A1
(en)
*
|
2007-10-15 |
2012-12-26 |
Capsugel Belgium NV |
Linkers for multipart dosage forms for release of one or more parmaceutical compositions, and the resulting dosage forms
|
|
US20090110724A1
(en)
*
|
2007-10-31 |
2009-04-30 |
Everett Laboratories, Inc. |
Compositions and methods for treatment of pain
|
|
CA2704778C
(en)
*
|
2007-11-05 |
2014-04-29 |
Scolr Pharma, Inc. |
Formulations for enhanced bioavailability of orally administered polar agents
|
|
US9138430B2
(en)
*
|
2007-12-27 |
2015-09-22 |
Mylan Specialty L.P. |
Formulation and method for the release of paroxetine in the large intestine
|
|
WO2009085306A1
(en)
|
2007-12-28 |
2009-07-09 |
Impax Laboratories, Inc. |
Controlled release formulations of levodopa and uses thereof
|
|
DK2240155T3
(da)
|
2008-02-13 |
2012-09-17 |
Intarcia Therapeutics Inc |
Indretninger, formuleringer og fremgangsmåder til levering af flere gavnlige midler
|
|
EP2281058B1
(en)
|
2008-04-02 |
2016-06-29 |
Opko Ireland Global Holdings, Ltd. |
Methods, compositions, uses, and kits useful for vitamin d deficiency and related disorders
|
|
US20090311335A1
(en)
*
|
2008-06-12 |
2009-12-17 |
Scott Jenkins |
Combination of a triptan and an nsaid
|
|
CA2757979A1
(en)
*
|
2009-04-09 |
2010-10-14 |
Alkermes Pharma Ireland Limited |
Controlled-release clozapine compositions
|
|
DK2442791T3
(da)
|
2009-06-16 |
2020-03-02 |
Pfizer |
Former til dosering af apixaban
|
|
WO2011006066A1
(en)
|
2009-07-10 |
2011-01-13 |
Ironwood Pharmaceuticals, Inc. |
Cb receptor agonists
|
|
CN101596174B
(zh)
*
|
2009-07-13 |
2011-04-06 |
北京航洋胶囊技术有限公司 |
一种软胶囊及其制备方法
|
|
EP3735944A1
(en)
|
2009-09-28 |
2020-11-11 |
Intarcia Therapeutics, Inc. |
Rapid establishment and/or termination of substantial steady-state drug delivery
|
|
CN102781259A
(zh)
|
2009-09-30 |
2012-11-14 |
加利福尼亚大学董事会 |
辅因子及个体使用方法
|
|
CA2777856A1
(en)
|
2009-10-16 |
2011-04-21 |
Ranbaxy Laboratories Limited |
Extended release pharmaceutical compositions of paliperidone and processes of preparation thereof
|
|
CA2782556C
(en)
|
2009-12-02 |
2018-03-27 |
Adamas Pharmaceuticals, Inc. |
Amantadine compositions and methods of use
|
|
EP2516416A1
(en)
|
2009-12-23 |
2012-10-31 |
Ironwood Pharmaceuticals, Inc. |
Crth2 modulators
|
|
WO2011100359A1
(en)
|
2010-02-09 |
2011-08-18 |
Ironwood Pharmaceuticals, Inc. |
Cannabinoid agonists
|
|
US20130196960A1
(en)
|
2010-02-09 |
2013-08-01 |
Ironwood Pharmaceuticals, Inc. |
Cannabinoid Receptor Agonists
|
|
US20130178475A1
(en)
|
2010-03-17 |
2013-07-11 |
Ironwood Pharmaceuticals, Inc. |
sGC STIMULATORS
|
|
US8486013B2
(en)
*
|
2010-03-18 |
2013-07-16 |
Biotronik Ag |
Balloon catheter having coating
|
|
EP3636280A1
(en)
|
2010-03-29 |
2020-04-15 |
Opko Ireland Global Holdings, Ltd. |
Methods and compositions for reducing parathyroid levels
|
|
US8993572B2
(en)
*
|
2010-04-22 |
2015-03-31 |
Intra-Cellular Therapies, Inc. |
Pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines derivatives and [1,4]oxazino[2,3,4-hi]pyrido[4,3-b]indole derivatives
|
|
WO2011161666A2
(en)
*
|
2010-06-21 |
2011-12-29 |
White Innovation Ltd. |
Enclosed liquid capsules
|
|
AR088020A1
(es)
|
2010-06-30 |
2014-05-07 |
Ironwood Pharmaceuticals Inc |
Compuestos heterociclicos como estimuladores de sgc
|
|
US20130216552A1
(en)
|
2010-07-12 |
2013-08-22 |
Ironwood Pharmaceuticals, Inc. |
Crth2 modulators
|
|
US20130259830A1
(en)
|
2010-07-12 |
2013-10-03 |
Ironwood Pharmaceuticals, Inc. |
Crth2 modulators
|
|
CA2817319A1
(en)
|
2010-11-09 |
2012-05-18 |
Ironwood Pharmaceuticals, Inc. |
Triazole derivatives as sgc stimulators
|
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
|
CN108261547A
(zh)
|
2011-07-15 |
2018-07-10 |
纽斯尔特科学公司 |
用于调节代谢途径的组合物和方法
|
|
TWI615155B
(zh)
*
|
2011-11-01 |
2018-02-21 |
拜耳股份有限公司 |
滲透活性的陰道遞送系統
|
|
CN104066731B
(zh)
|
2011-12-27 |
2016-06-15 |
铁木医药有限公司 |
可用作sgc刺激剂的2-苄基、3-(嘧啶-2-基)取代的吡唑类
|
|
CN103211797B
(zh)
*
|
2012-01-18 |
2017-06-06 |
北京天衡医院管理有限公司 |
盐酸维拉帕米膜控缓释微丸胶囊
|
|
US9198454B2
(en)
|
2012-03-08 |
2015-12-01 |
Nusirt Sciences, Inc. |
Compositions, methods, and kits for regulating energy metabolism
|
|
US20150080381A1
(en)
|
2012-04-12 |
2015-03-19 |
Ironwood Pharmaceuticals, Inc. |
Methods of treating alopecia and acne
|
|
WO2013155506A1
(en)
|
2012-04-14 |
2013-10-17 |
Intra-Cellular Therapies, Inc. |
Novel compositions and methods
|
|
MX2014013205A
(es)
*
|
2012-04-30 |
2015-05-14 |
Dow Agrosciences Llc |
Vehículos de suministro de composición pesticida.
|
|
US11312878B2
(en)
*
|
2012-07-23 |
2022-04-26 |
Lotte Fine Chemical Co., Ltd. |
Aqueous composition for preparing hard capsule, preparation method therefor, hard capsule, and method for recycling hard capsule scraps
|
|
US9309235B2
(en)
|
2012-09-18 |
2016-04-12 |
Ironwood Pharmaceuticals, Inc. |
SGC stimulators
|
|
CA2885645A1
(en)
|
2012-09-19 |
2014-03-27 |
Ironwood Pharmaceuticals, Inc. |
Sgc stimulators
|
|
US9943517B2
(en)
|
2012-11-13 |
2018-04-17 |
Nusirt Sciences, Inc. |
Compositions and methods for increasing energy metabolism
|
|
WO2014113404A1
(en)
|
2013-01-15 |
2014-07-24 |
Nusirt Sciences, Inc. |
Treating pulmonary conditions
|
|
GB201303781D0
(en)
|
2013-03-04 |
2013-04-17 |
Gauthier Pierre Pascal |
Oral timer device and method of using same
|
|
KR101847947B1
(ko)
|
2013-03-15 |
2018-05-28 |
옵코 아이피 홀딩스 Ⅱ 인코포레이티드 |
안정화되고 변형된 비타민 ｄ 방출 제형
|
|
JP6550370B2
(ja)
|
2013-03-15 |
2019-07-24 |
ニューサート サイエンシーズ， インコーポレイテッド |
脂質レベルを低下させるロイシンおよびニコチン酸
|
|
EP2968320B1
(en)
|
2013-03-15 |
2020-11-11 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
US20140275038A1
(en)
|
2013-03-15 |
2014-09-18 |
Inspirion Delivery Technologies, Llc |
Abuse deterrent compositions and methods of use
|
|
KR102362835B1
(ko)
|
2013-03-15 |
2022-02-14 |
사이클리온 테라퓨틱스, 인크. |
ｓＧＣ 자극인자
|
|
CN103315973B
(zh)
*
|
2013-05-24 |
2014-05-07 |
杭州和正医药有限公司 |
喹硫平的渗透泵型控释制剂
|
|
US10154971B2
(en)
|
2013-06-17 |
2018-12-18 |
Adamas Pharma, Llc |
Methods of administering amantadine
|
|
EP2839853A1
(de)
*
|
2013-08-23 |
2015-02-25 |
LTS LOHMANN Therapie-Systeme AG |
Transdermales therapeutisches System mit Druckerzeugungsvorrichtung
|
|
US10987313B2
(en)
|
2013-10-07 |
2021-04-27 |
Impax Laboratories, Llc |
Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
|
|
EP3054929B1
(en)
|
2013-10-07 |
2020-08-05 |
Impax Laboratories, LLC |
Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
|
|
KR102495941B1
(ko)
|
2013-12-03 |
2023-02-06 |
인트라-셀룰라 써래피스, 인코퍼레이티드. |
신규한 방법
|
|
CA2933250A1
(en)
|
2013-12-11 |
2015-06-18 |
Ironwood Pharmaceuticals, Inc. |
Sgc stimulators
|
|
KR102199596B1
(ko)
*
|
2013-12-31 |
2021-01-07 |
롯데정밀화학 주식회사 |
경질 캡슐용 수성 조성물 및 이를 사용하여 제조된 경질 캡슐
|
|
KR102161001B1
(ko)
*
|
2013-12-31 |
2020-09-29 |
롯데정밀화학 주식회사 |
경질 캡슐용 수성 조성물 및 이를 사용하여 제조된 경질 캡슐
|
|
EP3110507B1
(en)
|
2014-02-27 |
2020-11-18 |
NuSirt Sciences, Inc. |
Compositions and methods for the reduction or prevention of hepatic steatosis
|
|
PT3125893T
(pt)
|
2014-04-04 |
2023-11-21 |
Intra Cellular Therapies Inc |
Gama-carbolinas fusionadas com heterociclo deuterado como antagonistas de recetores 5-ht2a
|
|
MX2016013046A
(es)
|
2014-04-04 |
2017-02-15 |
Intra Cellular Therapies Inc |
Compuestos organicos.
|
|
US10179776B2
(en)
|
2014-06-09 |
2019-01-15 |
Intra-Cellular Therapies, Inc. |
Compounds and methods of use to treat schizophrenia
|
|
US10220047B2
(en)
|
2014-08-07 |
2019-03-05 |
Opko Ireland Global Holdings, Ltd. |
Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
|
|
US10729685B2
(en)
|
2014-09-15 |
2020-08-04 |
Ohemo Life Sciences Inc. |
Orally administrable compositions and methods of deterring abuse by intranasal administration
|
|
US20170298055A1
(en)
|
2014-09-17 |
2017-10-19 |
Ironwood Pharmaceuticals, Inc. |
sGC STIMULATORS
|
|
JP2017527604A
(ja)
|
2014-09-17 |
2017-09-21 |
アイアンウッド ファーマシューティカルズ インコーポレイテッド |
ｓＧＣ刺激剤
|
|
MX2017003516A
(es)
|
2014-09-17 |
2017-07-28 |
Ironwood Pharmaceuticals Inc |
Derivados de pirazol como estimuladores de guanilato ciclasa soluble (sgc).
|
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
|
US9808608B2
(en)
*
|
2014-11-16 |
2017-11-07 |
International Business Machines Corporation |
Helical coil delivery device for active agent
|
|
MA44390A
(fr)
|
2015-06-03 |
2019-01-23 |
Intarcia Therapeutics Inc |
Systèmes de mise en place et de retrait d'implant
|
|
US20170119680A1
(en)
|
2015-10-30 |
2017-05-04 |
R.P. Scherer Technologies, Llc |
Extended release film-coated capsules
|
|
EP3397253A1
(en)
|
2015-12-30 |
2018-11-07 |
Adamas Pharmaceuticals, Inc. |
Methods and compositions for the treatment of seizure-related disorders
|
|
KR20180099905A
(ko)
|
2016-01-26 |
2018-09-05 |
인트라-셀룰라 써래피스, 인코퍼레이티드. |
유기 화합물
|
|
IL297676B2
(en)
|
2016-03-25 |
2023-12-01 |
Intra Cellular Therapies Inc |
A controlled or delayed release pharmaceutical preparation containing a deuterated compound
|
|
KR20180123100A
(ko)
|
2016-03-28 |
2018-11-14 |
옵코 아일랜드 글로벌 홀딩스 리미티드 |
비타민 d 치료 방법
|
|
JP2019510039A
(ja)
|
2016-03-28 |
2019-04-11 |
イントラ−セルラー・セラピーズ・インコーポレイテッドＩｎｔｒａ−Ｃｅｌｌｕｌａｒ Ｔｈｅｒａｐｉｅｓ， Ｉｎｃ． |
新規組成物および方法
|
|
WO2017200943A1
(en)
|
2016-05-16 |
2017-11-23 |
Intarcia Therapeutics, Inc. |
Glucagon-receptor selective polypeptides and methods of use thereof
|
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
|
CA3028450A1
(en)
*
|
2016-07-06 |
2018-01-11 |
Durect Corporation |
Oral dosage form with drug composition, barrier layer and drug layer
|
|
IL292968A
(en)
|
2016-09-02 |
2022-07-01 |
Cyclerion Therapeutics Inc |
scg motors in converging cycles
|
|
EP3525763A4
(en)
|
2016-10-12 |
2020-06-17 |
Intra-Cellular Therapies, Inc. |
AMORPHE FIXED DISPERSIONS
|
|
EP3538096B1
(en)
|
2016-11-08 |
2024-02-28 |
Tisento Therapeutics Inc. |
Treatment of cns diseases with sgc stimulators
|
|
CA3042713A1
(en)
|
2016-11-08 |
2018-05-17 |
Cyclerion Therapeutics, Inc. |
Sgc stimulators
|
|
WO2018126140A1
(en)
|
2016-12-29 |
2018-07-05 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
JP6987868B2
(ja)
|
2016-12-29 |
2022-01-05 |
イントラ−セルラー・セラピーズ・インコーポレイテッドIntra−Cellular Therapies, Inc. |
有機化合物
|
|
IL267736B2
(en)
|
2017-01-03 |
2024-03-01 |
Intarcia Therapeutics Inc |
Methods involving continuous administration of a GLP-1 receptor agonist and co-administration of a drug
|
|
WO2018175969A1
(en)
|
2017-03-24 |
2018-09-27 |
Intra-Cellular Therapies, Inc. |
Novel compositions and methods
|
|
WO2018200885A1
(en)
|
2017-04-26 |
2018-11-01 |
Neurocentria, Inc. |
Magnesium compositions and methods of use
|
|
WO2019023063A1
(en)
|
2017-07-26 |
2019-01-31 |
Intra-Cellular Therapies, Inc. |
ORGANIC COMPOUNDS
|
|
IL272249B2
(en)
|
2017-07-26 |
2023-11-01 |
Intra Cellular Therapies Inc |
organic compounds
|
|
MX2020009668A
(es)
|
2018-03-16 |
2021-01-08 |
Intra Cellular Therapies Inc |
Métodos novedosos.
|
|
US20210009592A1
(en)
|
2018-03-23 |
2021-01-14 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
EP3768254B1
(en)
|
2018-03-23 |
2024-10-02 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
CN111989158B
(zh)
*
|
2018-04-15 |
2022-08-12 |
奥普图弗卢迪克生物鉴定有限责任公司 |
压差辅助排水系统
|
|
CA3102948A1
(en)
|
2018-06-08 |
2019-12-12 |
Intra-Cellular Therapies, Inc. |
Novel methods
|
|
WO2019241278A1
(en)
|
2018-06-11 |
2019-12-19 |
Intra-Cellular Therapies, Inc. |
Substituted heterocycle fused gamma-carbolines synthesis
|
|
USD933219S1
(en)
|
2018-07-13 |
2021-10-12 |
Intarcia Therapeutics, Inc. |
Implant removal tool and assembly
|
|
EP3843738A4
(en)
|
2018-08-31 |
2022-06-01 |
Intra-Cellular Therapies, Inc. |
NEW METHODS
|
|
BR112021003838A2
(pt)
|
2018-08-31 |
2021-05-18 |
Intra-Cellular Therapies, Inc. |
métodos novos
|
|
CA3141223A1
(en)
|
2019-07-07 |
2021-01-14 |
Sharon Mates |
Novel methods
|
|
US10940088B1
(en)
*
|
2020-01-09 |
2021-03-09 |
King Saud University |
Method of preparing low dose pharmaceutical formulations
|
|
CN112641751B
(zh)
*
|
2020-09-25 |
2022-06-21 |
广州玖洲胶囊生物科技有限公司 |
一种羟丙甲基纤维素和卡拉胶的填充空心充液胶囊
|
|
US11986449B2
(en)
|
2020-12-22 |
2024-05-21 |
Amneal Pharmaceuticals Llc |
Levodopa dosing regimen
|
|
WO2024145659A1
(en)
|
2022-12-30 |
2024-07-04 |
Intra-Cellular Therapies, Inc. |
Heterocycle fused gamma-carbolines acting on the serotonine 5-ht2a receptor
|